347 related articles for article (PubMed ID: 16009498)
1. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
2. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
[TBL] [Abstract][Full Text] [Related]
3. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
[TBL] [Abstract][Full Text] [Related]
5. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.
Kilic E; Kilic U; Reiter RJ; Bassetti CL; Hermann DM
J Pineal Res; 2005 Sep; 39(2):151-5. PubMed ID: 16098092
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
Die J; Wang K; Fan L; Jiang Y; Shi Z
Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
[TBL] [Abstract][Full Text] [Related]
8. Intravenous rosuvastatin for acute stroke treatment: an animal study.
Prinz V; Laufs U; Gertz K; Kronenberg G; Balkaya M; Leithner C; Lindauer U; Endres M
Stroke; 2008 Feb; 39(2):433-8. PubMed ID: 18162625
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice.
Kilic U; Kilic E; Reiter RJ; Bassetti CL; Hermann DM
J Pineal Res; 2005 Jan; 38(1):67-71. PubMed ID: 15617539
[TBL] [Abstract][Full Text] [Related]
10. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.
Nishimura M; Izumiya Y; Higuchi A; Shibata R; Qiu J; Kudo C; Shin HK; Moskowitz MA; Ouchi N
Circulation; 2008 Jan; 117(2):216-23. PubMed ID: 18158361
[TBL] [Abstract][Full Text] [Related]
12. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
13. TLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration.
Kilic U; Kilic E; Matter CM; Bassetti CL; Hermann DM
Neurobiol Dis; 2008 Jul; 31(1):33-40. PubMed ID: 18486483
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.
Ma M; Uekawa K; Hasegawa Y; Nakagawa T; Katayama T; Sueta D; Toyama K; Kataoka K; Koibuchi N; Kuratsu J; Kim-Mitsuyama S
Brain Res; 2013 Jun; 1519():87-94. PubMed ID: 23632378
[TBL] [Abstract][Full Text] [Related]
16. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
Engelhorn T; Doerfler A; Heusch G; Schulz R
Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.
Famer D; Wahlund LO; Crisby M
Biochem Biophys Res Commun; 2010 Nov; 402(2):367-72. PubMed ID: 20946880
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.
Mayanagi K; Katakam PV; Gáspár T; Domoki F; Busija DW
J Cereb Blood Flow Metab; 2008 Dec; 28(12):1927-35. PubMed ID: 18665182
[TBL] [Abstract][Full Text] [Related]
19. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning.
Cho S; Park EM; Zhou P; Frys K; Ross ME; Iadecola C
J Cereb Blood Flow Metab; 2005 Apr; 25(4):493-501. PubMed ID: 15689953
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke.
Chaudhry K; Rogers R; Guo M; Lai Q; Goel G; Liebelt B; Ji X; Curry A; Carranza A; Jimenez DF; Ding Y
Neurosci Lett; 2010 Apr; 474(2):109-14. PubMed ID: 20298757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
